MedPro Rx, Inc. Awards 67 Scholarships Nationwide To Students Living With Bleeding Disorders

Raleigh, NC (PressExposure) August 24, 2008 -- Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy awarded 67 scholarships in 29 states for students living with bleeding disorders. Since starting its “Education is Power” scholarship program in 2006, MedPro Rx has distributed $135,000 to students nationwide who have either hemophilia or von Willebrand Disease (vWD). The annual scholarships are open to United States residents who are living with a bleeding disorder, entering or attending a community college, junior college, four-year college, university or vocational school, and active in their community.

Hemophilia is a rare, hereditary disorder that causes excessive bleeding to occur spontaneously or after injury. The bleeding may be external or internal into joints, muscles, the abdominal cavity, the brain and other organs. Hemophilia affects approximately 20,000 people nationwide, crossing all racial and socioeconomic groups, with a higher incidence among males. The three most common types of hemophilia are Hemophilia A or Factor VIII Deficiency, Hemophilia B or Factor IX Deficiency, and von Willebrand Disease (vWD). von Willebrand Disease is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. Unlike hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints.

For more information about MedPro Rx’s “Education is Power” program or their pharmacy services, visit http://www.medprorx.com or call (888) 571-3100.

Related Links: http://www.medprorx.com [http://www.medprorx.com/hemophilia_scholarship.php] http://www.cdc.gov/ncbddd/hbd/hemophilia.htm http://www.mmimarketing.com

News Facts:

• Nancy McFarlane, president of MedPro Rx (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy awarded 67 scholarships in 29 states for students living with bleeding disorders. • Since starting its “Education is Power” scholarship program in 2006, MedPro has distributed $135,000 to students who have either hemophilia or von Willebrand Disease. • The program is open to United States residents who are living with a bleeding disorder, entering or attending a community college, junior college, four-year college, university or vocational school, and active in their community. • Hemophilia is a rare, hereditary disorder that causes excessive bleeding to occur spontaneously or after injury. • The bleeding may be external or internal into joints, muscles, the abdominal cavity, the brain and other organs. • Hemophilia affects approximately 20,000 people nationwide, crossing all racial and socioeconomic groups, with a higher incidence among males. • The three most common types of hemophilia are Hemophilia A or Factor VIII Deficiency, Hemophilia B or Factor IX Deficiency, and von Willebrand Disease (vWD). • von Willebrand Disease is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. • Unlike hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints. • For more information about MedPro Rx’s “Education is Power” program or their pharmacy services, visit http://www.medprorx.com or call (888) 571-3100.

Quotes: “We are honored to support the education of students living with hemophilia,” McFarlane said. “Students from the bleeding disorder community face a unique set of challenges, and I am happy that MedPro Rx can help ease some of the financial burden.”

“We are extremely pleased by the overwhelming response to our scholarship program”, said Kathy Robinette-Stoneberg, scholarship coordinator for MedPro Rx. “The increase in participation from last year shows the value and importance of the program to the bleeding disorders community.”

About MedPro Rx, Inc.: MedPro Rx, Inc. is a specialty infusion pharmacy which has been providing infused and injectable medications and services to clients with chronic illnesses since 2002. With more than 100 years of combined pharmacy, nursing and management experience, MedPro Rx is dedicated to improving the overall outcomes of the client therapy experience. MedPro Rx’s goal is to set the standard for infusion care and achieve positive clinical outcomes for clients by participating in the healthcare process through integrated, community-based systems. As a specialty infusion pharmacy, MedPro Rx is an Accreditation Commission for Health Care, Inc. provider (ACHC) whose services emphasize treatments for individuals with hemophilia, vWD, autoimmune neuromuscular disorders and other complex chronic conditions. Services include client and family advocacy, complimentary pick-up of sharps containers at the client’s location of choice, express shipping and personal medication delivery services, complete insurance and benefit counseling, and the assurance that MedPro Rx stocks all factor and IVIg brands, all doses from all manufacturers, all the time. MedPro Rx offers specialty intravenous therapies such as IVIg, which treats a variety of immunodeficient diagnoses, and clotting factor for a client to use in their home, at infusion clinics and in the physicians’ offices. For more information or to receive a free consultation and health insurance evaluation, please call (888) 571-3100 or visit http://www.medprorx.com.

About MMI ASSOCIATES, INC.

Patty Briguglio
MMI Associates, Inc.
(919) 233-6600
patty@mmimarketing.com
PR Firms Raleigh, NC

Press Release Source: http://PressExposure.com/PR/MMI_ASSOCIATES,_INC..html

Press Release Submitted On: August 15, 2008 at 9:57 am
This article has been viewed 20354 time(s).